Adam Rosendorff, MD, is a Harvard-trained clinical pathologist specializing in laboratory medicine. He is the Founder and CEO of GilaRiverMD, LLC, and serves as a clinical laboratory director in California. His clinical focus includes laboratory diagnostics and test interpretation, genomics and precision medicine, and metabolic health. His research interests center on diagnostic genomics, quality and innovation in laboratory medicine, and improving access to actionable diagnostics for underserved populations. He has been recognized with the Howard Hughes Medical Institute Physician Scientist Early Career Award, a Leukemia & Lymphoma Society grant, and the Morris B. Bender Family Prize for Clinical Neurology, and has led multiple clinical laboratories as laboratory director. Dr. Rosendorff earned his medical degree from the Icahn School of Medicine at Mount Sinai, completed an internal medicine internship at Brown University/Rhode Island Hospital–Lifespan, and a residency in anatomic and clinical pathology at Brigham and Women’s Hospital, followed by a post‑doctoral fellowship in infectious diseases.
Attending Physician
Medical School
1996 – 2000
Residency
2000 – 2001
Fellowship
2005 – present